Botulinum Toxin Type B (MyoBloc) in the Management of Hyperkinetic Facial Lines
- 1 May 2002
- journal article
- clinical trial
- Published by Wiley in Otolaryngology -- Head and Neck Surgery
- Vol. 126 (5) , 459-467
- https://doi.org/10.1067/mhn.2002.124706
Abstract
OBJECTIVE: Our goal was to evaluate the safety and efficacy of botulinum toxin type B (BTX-B) in the management of hyperfunctional facial lines.STUDY DESIGN AND SETTING: Twenty-four patients from a...Keywords
This publication has 15 references indexed in Scilit:
- Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacologySeminars in Cutaneous Medicine and Surgery, 2001
- Botulinum Toxin: Basic Science and Clinical Uses in OtolaryngologyThe Laryngoscope, 2001
- Temporal Brow Lift Using Botulinum Toxin APlastic and Reconstructive Surgery, 2000
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystoniaNeurology, 1999
- The cosmetic uses of Botulinum toxin type AInternational Journal of Dermatology, 1999
- The Management of Hyperfunctional Facial Lines With Botulinum ToxinJAMA Otolaryngology–Head & Neck Surgery, 1997
- Botulinum toxin type B in the treatment of cervical dystoniaNeurology, 1995
- Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled StudyPlastic and Reconstructive Surgery, 1994
- Aesthetic Indications for Botulinum Toxin InjectionPlastic and Reconstructive Surgery, 1994
- Botulinum Toxin for the Treatment of Hyperfunctional Lines of the FaceJAMA Otolaryngology–Head & Neck Surgery, 1993